The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Primary Epstein-Barr virus infection
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
HAUSEN, H. Z., SCHULTE-HOLTHAUSEN, H., KLEIN, G., HENLE, W., HENLE, G., CLIFFORD, P., & SANTESSON, L. (1970) · Nature · doi:10.1038/2281056a0 · Cited by 1,254
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
Arvin, A. M., Campadelli‐Fiume, G., Mocarski, E. S., Moore, P. S., Roizman, B., Whitley, R. J., & Yamanishi, K. (2007) · Cited by 844
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., & Rickinson, A. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02568.x · Cited by 711
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes
Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4084-4092.1990 · Cited by 497
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Müller‐Hermelink, H. K., Vardiman, J. W., Lister, T. A., & Bloomfield, C. D. (2000) · Modern Pathology · doi:10.1038/modpathol.3880035 · Cited by 445
Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis
Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J.-S., Madsen, M., Rosdahl, N., Konradsen, H. B., Storm, H. H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023141 · Cited by 433
Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Léonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523813 · Cited by 426
Primary infection with the Epstein‐Barr virus and risk of multiple sclerosis
Levin, L. I., Munger, K. L., O'Reilly, E. J., Falk, K. I., & Ascherio, A. (2010) · Annals of Neurology · doi:10.1002/ana.21978 · Cited by 404
Kalil, A. C., Levitsky, J., Lyden, E., Stoner, J., & Freifeld, A. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00005 · Cited by 389
Hodson, E. M., Jones, C. A., Webster, A. C., Strippoli, G. F., Barclay, P. G., Kable, K., Vimalachandra, D., & Craig, J. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66553-1 · Cited by 350
Banwell, B., Krupp, L., Kennedy, J., Tellier, R., Tenembaum, S., Ness, J., Belman, A., Boiko, A., Bykova, O., Waubant, E., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70196-5 · Cited by 344
Balfour, H. H., Odumade, O. A., Schmeling, D. O., Mullan, B. D., Ed, J. A., Knight, J. A., Vezina, H. E., Thomas, W., & Hogquist, K. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis646 · Cited by 337
Self-citationMORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Henle, G., Achong, B. G., & Barr, Y. M. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.121.5.761 · Cited by 334
THE PRESENCE OF HETEROPHILE ANTIBODIES IN INFECTIOUS MONONUCLEOSIS
Paul, J. R., & Bunnell, W. W. (1932) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193201000-00010 · Cited by 328
CULTIVATION IN VITRO OF HUMAN LYMPHOBLASTS FROM BURKITT'S MALIGNANT LYMPHOMA
Epstein, M. A., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92354-2 · Cited by 323
Hutt-Fletcher, L. M. (2007) · Journal of Virology · doi:10.1128/jvi.00445-07 · Cited by 323
Shibata, D. K., Tokunaga, M., Uemura, Y., Sato, E., Tanaka, S., & Weiss, L. M. (1991) · PubMed · Cited by 317
The initiation and prevention of multiple sclerosis
Ascherio, A., Munger, K. L., & Lünemann, J. D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.198 · Cited by 289
Balfour, H. H., Sifakis, F., Sliman, J. A., Knight, J. A., Schmeling, D. O., & Thomas, W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit321 · Cited by 266
Self-citationChijioke, O., Müller, A., Feederle, R., Barros, M. H. M., Krieg, C., Emmel, V., Marcenaro, E., Leung, C. S., Antsiferova, O., Landtwing, V., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.041 · Cited by 258
Acute complications of Epstein-Barr virus infectious mononucleosis
Jenson, H. B. (2000) · Current Opinion in Pediatrics · doi:10.1097/00008480-200006000-00016 · Cited by 233
Role for early-differentiated natural killer cells in infectious mononucleosis
Azzi, T., Lünemann, A., Murer, A., Ueda, S., Béziat, V., Malmberg, K.-J., Staubli, G., Gysin, C., Berger, C., Münz, C., et al. (2014) · Blood · doi:10.1182/blood-2014-01-553024 · Cited by 229
Crawford, D. H., Macsween, K. F., Higgins, C. D., Thomas, R., McAulay, K., Williams, H., Harrison, N., Reid, S., Conacher, M., Douglas, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505400 · Cited by 209
Balfour, Jr., Holman, C. J., Hokanson, K. M., Lelonek, M. M., Giesbrecht, J. E., White, D. R., Schmeling, D. O., Webb, C., Cavert, W., Wang, D. H., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/491740 · Cited by 200
The function of γδ T cells in innate immunity
Born, W. K., Reardon, C. L., & O’Brien, R. L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.007 · Cited by 198
Piriou, E., Asito, A. S., Sumba, P. O., Fiore, N., Middeldorp, J. M., Moormann, A. M., Ploutz-Snyder, R., & Rochford, R. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir872 · Cited by 182
Hochberg, D., Souza, T., Catalina, M., Sullivan, J. L., Luzuriaga, K., & Thorley-Lawson, D. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5194-5204.2004 · Cited by 181
Hendricks, D. W., Balfour, H. H., Dunmire, S. K., Schmeling, D. O., Hogquist, K. A., & Lanier, L. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303211 · Cited by 177
Self-citationPhase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis
Elliott, S. L., Suhrbier, A., Miles, J. J., Lawrence, G., Pye, S. J., Le, T. T., Rosenstengel, A., Nguyen, T. H., Allworth, A. M., Burrows, S. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01409-07 · Cited by 151
Jayasooriya, S., de Silva, T. I., Njie-Jobe, J., Sanyang, C., Leese, A. M., Bell, A. I., McAulay, K. A., Yanchun, P., Long, H. M., Dong, T., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004746 · Cited by 148
Prevalence of Epstein–Barr virus in Japan: Trends and future prediction
Takeuchi, K., Tanaka‐Taya, K., Kazuyama, Y., Ito, Y. M., Hashimoto, S., Fukayama, M., & Mori, S. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.01936.x · Cited by 145
Long, H. M., Chagoury, O. L., Leese, A. M., Ryan, G. B., James, E. A., Morton, L. T., Abbott, R. J. M., Sabbah, S., Kwok, W. W., & Rickinson, A. B. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121437 · Cited by 141
Rees, L., Tizard, E. J., Morgan, A. J., Cubitt, W. D., Finerty, S., Oyewole-Eletu, T., Owen, K., Royed, C., Stevens, S. J. C., Shroff, R. C., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181b9d918 · Cited by 127
Neurologic complications of infectious mononucleosis
Connelly, K. P., & DeWitt, L. D. (1994) · Pediatric Neurology · doi:10.1016/0887-8994(94)90021-3 · Cited by 121
Comprehensive review of post–organ transplant hematologic cancers
Dharnidharka, V. R. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14603 · Cited by 117
EBV MicroRNA BART16 Suppresses Type I IFN Signaling
Hooykaas, M. J. G., van Gent, M., Soppe, J. A., Kruse, E. M., Boer, I. G. J., van Leenen, D., Koerkamp, M. J. A. G., Holstege, F. C. P., Ressing, M. E., Wiertz, E. J. H. J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1501605 · Cited by 110
Epstein-Barr virus DNA is amplified in transformed lymphocytes
Sugden, B., Phelps, M., & Domoradzki, J. Y. (1979) · Journal of Virology · doi:10.1128/jvi.31.3.590-595.1979 · Cited by 107
Henle, G., & Henle, W. (1967) · PubMed · Cited by 104
Djaoud, Z., Guethlein, L. A., Horowitz, A., Azzi, T., Nemat‐Gorgani, N., Olive, D., Nadal, D., Norman, P. J., Münz, C., & Parham, P. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161017 · Cited by 93
A virologic pilot study of valacyclovir in infectious mononucleosis
Balfour, H. H., Hokanson, K. M., Schacherer, R. M., Fietzer, C. M., Schmeling, D. O., Holman, C., Vezina, H. E., & Brundage, R. C. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.02.002 · Cited by 90
Self-citationThe Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells
Hutt‐Fletcher, L. M. (2016) · Journal of Virology · doi:10.1128/jvi.01677-16 · Cited by 87
Mononucleosis and Athletic Participation: An Evidence-Based Subject Review
Putukian, M., O’Connor, F. G., Stricker, P. R., McGrew, C. A., Hosey, R. G., Gordon, S. M., Kinderknecht, J. J., Kriss, V. M., & Landry, G. L. (2008) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e31817e34f8 · Cited by 85
MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity
Albanese, M., Tagawa, T., Buschle, A., & Hammerschmidt, W. (2017) · Journal of Virology · doi:10.1128/jvi.01667-16 · Cited by 80
Gantt, S. M., Orem, J., Krantz, E. M., Morrow, R. A., Selke, S., Huang, M.-L. W., Schiffer, J. T., Jerome, K. R., Nakaganda, A., Wald, A., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw076 · Cited by 75
EBV gene expression and regulation
Young, L. S., Arrand, J. R., & Murray, P. G. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.028 · Cited by 73
Dunmire, S. K., Odumade, O. A., Porter, J. L., Genere, J. P. R., Schmeling, D. O., Bilgiç, H., Fan, D., Baechler, E. C., Balfour, H. H., & Hogquist, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085422 · Cited by 58
Self-citationProspective studies of infectious mononucleosis in university students
Grimm, J., Schmeling, D. O., Dunmire, S. K., Knight, J. A., Mullan, B. D., Ed, J. A., Brundage, R. C., Hogquist, K. A., & Balfour, H. H. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.48 · Cited by 54
Self-citationEBV and MS: Major cause, minor contribution or red-herring?
Burnard, S. M., Lechner‐Scott, J., & Scott, R. J. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.06.002 · Cited by 45
The Changing Epidemiology of Infectious Mononucleosis?
Morris, M. C., & Edmunds, W. J. (2002) · Journal of Infection · doi:10.1053/jinf.2002.1022 · Cited by 43
Rostgaard, K., Wohlfahrt, J., & Hjalgrim, H. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu204 · Cited by 43
Guerrero-Ramos, A., Patel, M., Kadakia, K., & Haque, T. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00754-13 · Cited by 42
Butler, L., Neilands, T. B., Mosam, A., Mzolo, S., & Martin, J. N. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02474.x · Cited by 31
γδ Cells and the Regulation of Mucosal Immune Responses
Hayday, A., Roberts, S. J., & Ramsburg, E. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.supplement_3.15tac4 · Cited by 31
Panikkar, A., Smith, C., Hislop, A. D., Tellam, N., Dasari, V., Hogquist, K. A., Wykes, M., Moss, D. J., Rickinson, A. B., Balfour, H. H., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv340 · Cited by 27
Self-citationBlake, J. M., Edwards, J. M., Fletcher, W., McSwiggan, D. A., & Pereira, M. S. (1976) · Journal of Clinical Pathology · doi:10.1136/jcp.29.9.841 · Cited by 24
Gammaherpesviruses entry and early events during infection
Chandran, B., & Hutt‐Fletcher, L. M. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.024 · Cited by 19
Cited by
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049
Molecular mimicry and autoimmunity
Rojas, M., Restrepo-Jiménez, P., Monsalve, D. M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Anaya, J.-M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.012 · Cited by 627
Epstein–Barr virus and multiple sclerosis
Soldan, S. S., & Lieberman, P. M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00770-5 · Cited by 467
Epstein-Barr Virus and Systemic Autoimmune Diseases
Houen, G., & Trier, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587380 · Cited by 379
Estimating the global burden of Epstein–Barr virus-related cancers
Wong, Y., Meehan, M. T., Burrows, S. R., Doolan, D. L., & Miles, J. J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03824-y · Cited by 314
Metadata
- Authors
- Dunmire, S. K., Verghese, P. S., & Balfour, H. H.
- Venue
- Journal of Clinical Virology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 102
- Pages
- 84-92
- ISSN
- 1386-6532 (ISSN-L)
- OpenAlex
- W2790846487
- Cited by
- 520
- References
- 60
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.